当前位置:主页 > 医学论文 > 神经病学论文 >

脑梗死患者rt-PA静脉溶栓治疗3个月末卒中后抑郁的临床分析

发布时间:2018-05-01 06:26

  本文选题:脑梗死 + 静脉溶栓 ; 参考:《大连医科大学》2017年硕士论文


【摘要】:目的:本研究通过收集大连医科大学附属第一医院神经内科脑梗死患者的相关信息,旨在描述脑梗死患者rt-PA静脉溶栓治疗3个月末卒中后抑郁(Post-Stroke Depression,PSD)的发生率及严重程度,分析卒中后抑郁的可能影响因素,进而探讨各影响因素与rt-PA静脉溶栓治疗脑梗死患者出现卒中后抑郁的不同程度之间的关系。方法:选择2016年1月1日至2016年10月31日期间大连医科大学附属第一医院神经内科收治的符合入组标准的脑梗死患者为研究对象,本次研究经随访3个月剔出失访及死亡患者后,入组103例患者,其中男性患者70例,占67.96%,女性患者33例,占32.04%,男女比例2.12:1。按照是否接受rt-PA静脉溶栓治疗分为溶栓组和非溶栓组(对照组),按照自制调查表(自制患者基本信息采集表、自制出院患者随访表)收集患者各项临床资料,记录患者患病3个月末NIHSS(NationalInstitutes of Health Stroke scale)评分、mRS(modified Rankin Scale)评分、HAMD-17(Hamilton Depression Scale)评分。首先根据是否接受溶栓治疗比较两组患者基线资料是否存在差异,再对卒中后抑郁发生率及抑郁严重程度进行分析;探讨脑梗死患者3个月末卒中后抑郁的相关影响因素,进而比较主要影响因素与患者不同抑郁程度之间的关系。使用SPSS19.0软件包建立数据库,采用t检验、卡方检验、秩和检验、单因素分析、多因素条件Logistic回归分析进行数据处理以及统计学分析。结果:1、103例脑梗死患者一般资料的组间比较差异无统计学意义(P0.05)。2、在103例脑梗死患者中,3个月末发生卒中后抑郁患者35例,发生率为33.98%。其中溶栓组3个月末发生卒中后抑郁患者为14例,发生率占103例脑梗死患者的13.59%,占溶栓组患者的25.00%;非溶栓组3个月末发生卒中后抑郁患者为21例,发生率占103例脑梗死患者的20.39%,占非溶栓组患者的44.68%。对溶栓组和非溶栓组3个月末卒中后抑郁的发生率进行比较,结果显示:溶栓组无抑郁的患者占103例脑梗死患者的比例明显高于非溶栓组,非溶栓组发生抑郁的患者占103例脑梗死患者的比例明显高于溶栓组。两组患者的卒中后抑郁程度差异有统计学意义(P=0.031)。3、在选取的可能对脑梗死患者3个月卒中后抑郁产生影响的16项因素中,其中3项因素:护理人员(P=0.017)、3个月末的mRS评分(P=0.004)以及静脉溶栓治疗溶栓(P=0.013)是脑梗死患者3个月末卒中后抑郁的影响因素。4、护理人员对患者发生重度抑郁的影响差异有统计学意义(P=0.002);患者的3个月末的mRS评分对轻度、中度以及重度三种不同程度卒中后抑郁均有影响,差异均有统计学意义(P=0.006,P=0.000,P=0.000);溶栓治疗对患者发生重度抑郁的影响差异有统计学意义(P=0.045)。其中溶栓组中,患者的3个月末的mRS评分对患者轻度、中度以及重度三种不同程度卒中后抑郁均有影响,差异有统计学意义(P=0.004,P=0.000,P=0.024);非溶栓组中,护理人员对患者发生重度抑郁的影响差异有统计学意义(P=0.007);患者的3个月末的mRS评分对轻度、中度以及重度三种不同程度卒中后抑郁均有影响,差异有统计学意义(P=0.019,P=0.002,P=0.006)。结论:1、rt-PA静脉溶栓治疗不仅可以明显减少脑梗死患者3个月末卒中后抑郁的发生,而且还能够明显降低脑梗死患者3个月末卒中后抑郁的严重程度;2、护理人员、3个月末mRS评分和静脉溶栓治疗与脑梗死患者3个月末PSD发生相关;3、不同的护理人员(家属护理/护工护理)与脑梗死患者(特别是非静脉溶栓治疗的脑梗死患者)3个月末重度卒中后抑郁的发生相关;脑梗死患者3个月末神经功能改善情况与其3个月末轻度、中度、重度抑郁的发生相关;脑梗死患者急性期接受溶栓治疗与脑梗死患者3个月末重度卒中后抑郁的发生相关。
[Abstract]:Objective: This study aims to describe the incidence and severity of Post-Stroke Depression (PSD) in patients with cerebral infarction at the end of 3 months of cerebral infarction by collecting the related information of cerebral infarction in the Department of Neurology, the First Affiliated Hospital of Dalian Medical University, and to analyze the possible influencing factors of post stroke depression, and then to discuss the effects of each image. The relationship between sound factors and rt-PA intravenous thrombolytic therapy in the treatment of post-stroke depression in patients with cerebral infarction. Methods: selected patients who were admitted to the Department of Neurology of the First Affiliated Hospital of Dalian Medical University from January 1, 2016 to October 31, 2016 were selected as the subjects of cerebral infarction which were in accordance with the standard of entry group. This study was followed up for 3 months. After the loss of and death, 103 patients were enrolled in the group, of which 70 were male, 67.96% and 33 in women, accounting for 32.04%. 2.12:1. was divided into thrombolytic and non thrombolytic group (control group) according to whether rt-PA intravenous thrombolytic therapy was accepted, according to self-made questionnaire (self-made basic information collection table, homemade follow-up list of discharged patients) NIHSS (NationalInstitutes of Health Stroke scale) score, mRS (modified Rankin Scale) score, HAMD-17 (Hamilton) score were recorded at the end of 3 months of the patient's illness. First, whether there was a difference in baseline data between the two groups according to whether or not to accept thrombolytic therapy, and then the incidence of post stroke depression Analysis of the severity of depression and the related factors of post-stroke depression in patients with cerebral infarction at the end of 3 months, and then comparing the relationship between the main factors and the degree of depression in the patients. Using the SPSS19.0 software package to establish a database, using t test, chi square test, rank test, single factor analysis, and multiple factor conditional Logistic regression Data processing and statistical analysis were carried out. Results: there was no significant difference in the general data between 1103 patients with cerebral infarction (P0.05).2. Among the 103 patients with cerebral infarction, 35 cases of post-stroke depression occurred at the end of 3 months, the incidence of which was 33.98%. in the thrombolytic group and the incidence of post-stroke depression in 14 cases at the end of 3 months of thrombolytic therapy. 13.59% of the 103 patients with cerebral infarction accounted for 25% of the thrombolytic group, and 21 cases of post-stroke depression in the non thrombolytic group at the end of 3 months, accounting for 20.39% of the 103 patients with cerebral infarction, accounting for the incidence of post-stroke depression in the thrombolytic and non thrombolytic groups at the end of 3 months in the non thrombolytic group, and the results showed that the thrombolytic group had no inhibitory effect on the incidence of post-stroke depression at the end of 3 months. The results showed that there was no inhibition in thrombolytic group in the thrombolytic group. The results showed that the thrombolytic group had no inhibition on the incidence of depression after stroke. The results showed that the thrombolytic group had no inhibition on the incidence of depression after stroke. The results showed that the thrombolytic group had no inhibition on the incidence of depression after stroke. The proportion of depressed patients in 103 patients with cerebral infarction was significantly higher than that in non thrombolytic group. The proportion of 103 patients with cerebral infarction in the non thrombolytic group was significantly higher than that in thrombolytic group. The difference of post stroke depression in the two groups was statistically significant (P=0.031).3, and the selection could produce a shadow of post-stroke depression after 3 months of cerebral infarction. Of the 16 factors, 3 factors: the nursing staff (P=0.017), the mRS score at the end of 3 months (P=0.004) and the thrombolytic thrombolytic thrombolysis (P=0.013) were the factors affecting the post-stroke depression of the patients at the end of the cerebral infarction (.4), and the nursing staff had a statistically significant difference in the effect of severe depression (P=0.002), and the mRS at the end of the 3 month of the patient. The scores had significant effects on three different degrees of post-stroke depression in mild, moderate and severe cases (P=0.006, P=0.000, P=0.000), and the difference in the effect of thrombolytic therapy on severe depression was statistically significant (P=0.045). In the thrombolytic group, the patients' mRS scores at the end of 3 months were mild, moderate, and severe. Three different degrees of post-stroke depression had a significant difference (P=0.004, P=0.000, P=0.024); in the non thrombolytic group, the nursing staff had a significant difference in the effect of severe depression (P=0.007), and the mRS score at the end of 3 months had an effect on the mild, moderate and severe post-stroke depression in three different degrees, The difference was statistically significant (P=0.019, P=0.002, P=0.006). Conclusion: 1, rt-PA intravenous thrombolytic therapy can not only significantly reduce the incidence of post-stroke depression in patients with cerebral infarction at the end of 3 months, but also significantly reduce the severity of post-stroke depression in patients with cerebral infarction at the end of 3 months; 2, nursing staff, mRS scores and intravenous thrombolytic therapy at the end of 3 months, and the treatment of thrombolytic therapy at the end of 3 months. Patients with cerebral infarction were associated with PSD at the end of 3 months; 3, different nurses (family care / nursing care) were associated with the occurrence of severe post-stroke depression at the end of 3 months of cerebral infarction (especially in patients with cerebral infarction treated by non intravenous thrombolytic therapy); the improvement of nerve function at the end of 3 months of cerebral infarction was mild, moderate, and severe depression at the end of the month of 3 months. Thrombolytic therapy in patients with cerebral infarction at acute stage is associated with the occurrence of severe stroke depression at the end of 3 months in patients with cerebral infarction.

【学位授予单位】:大连医科大学
【学位级别】:硕士
【学位授予年份】:2017
【分类号】:R743.3

【相似文献】

相关期刊论文 前10条

1 郝静;脑卒中后抑郁对预后的影响[J];河南实用神经疾病杂志;2000年05期

2 单培彦,曹丽丽,迟兆富,麻琳,刘淑萍;卒中后抑郁状态影响因素的研究[J];中华老年医学杂志;2002年04期

3 ;脑卒中后抑郁和情感不适与发病部位的关系[J];中国临床康复;2002年11期

4 苏文大;脑卒中后抑郁相关因素分析[J];广东医学;2003年04期

5 孙忠华,潘秋兰,潘福祥;脑卒中后抑郁[J];神经疾病与精神卫生;2003年03期

6 凌先传;氟西汀治疗脑卒中后抑郁26例的疗效分析[J];四川精神卫生;2003年02期

7 钟雷,张继青;卒中后抑郁[J];医师进修杂志;2004年01期

8 吴丹红,李宗兰,沈向英,李承晏;脑卒中后抑郁及其相关因素[J];中国行为医学科学;2004年01期

9 黄恩,陈平,程韬;脑卒中后抑郁的心理干预对照研究[J];中华物理医学与康复杂志;2004年07期

10 杨雅莹,晏勇;脑卒中后抑郁的研究新进展[J];重庆医学;2004年09期

相关会议论文 前10条

1 赵嘉林;;额叶卒中后抑郁的临床研究[A];2006年浙江省神经病学学术年会论文汇编[C];2006年

2 龙登毅;;关注脑卒中后抑郁[A];第十二届全国老年医学进展学术会议暨江苏省中西医结合学会老年分会学术年会论文集[C];2012年

3 张巧俊;;卒中后抑郁的临床研究进展[A];中国康复医学会脑血管病专业委员会换届暨第十五次全国脑血管病康复学术年会、湖南省康复医学会神经康复专业委员会2012学术年会论文集[C];2012年

4 林源绍;邵蓓;王虹;Kevin O' Byrne;李晓锋;;降钙素基因相关肽在雌激素保护卒中后抑郁中的作用[A];2009香港-北京-杭州内科论坛暨2009年浙江省内科学学术年会论文汇编[C];2009年

5 朱敏初;朱文娟;;脑卒中后抑郁相关因素分析[A];中华医学会第12次全国内科学术会议论文汇编[C];2009年

6 王萍;段德香;卢红;赵敏;;中西医结合治疗卒中后抑郁的临床研究[A];第九届全国中西医结合治疗精神疾病学术研讨会论文集[C];2008年

7 孙惠红;;疏解平潜、健脾养(清)心法联合氟西汀治疗卒中后抑郁临床研究[A];甘肃省中医药学会2010年会员代表大会暨学术年会论文汇编[C];2010年

8 郭瑞友;王莉;李吉柱;赵丽霞;毛德军;;卒中后抑郁患者瘦素及胰岛素样生长因子-1的研究[A];中华中医药学会血栓病分会第四次学术研讨会暨广东省中医药学会血栓病专业委员会首届学术研讨会论文集[C];2010年

9 徐隽莹;肖艳;;脑卒中后抑郁的临床特征分析[A];中华医学会第十三次全国神经病学学术会议论文汇编[C];2010年

10 巩法莲;李运刚;;脑卒中后抑郁的干预对运动康复的影响[A];山东省心理卫生协会第二届学术研讨会优秀论文选编[C];2001年

相关重要报纸文章 前9条

1 记者 张昊;卒中后抑郁管理项目启动[N];健康报;2012年

2 本报记者 李颖;对卒中患者要少批评多鼓励[N];科技日报;2012年

3 辽溪;氟西汀治疗卒中后抑郁[N];中国医药报;2001年

4 编译 李译;卒中后女性比男性更易患抑郁[N];医药经济报;2009年

5 宋鲁平 柳妍;当心“卒中”变“抑郁”[N];北京科技报;2009年

6 本报记者 黄静;卒中患者提高生存质量方向在哪?[N];人民政协报;2012年

7 北京宣武医院神经内科副主任医师 詹淑琴;小心脑卒中后抑郁[N];健康时报;2003年

8 清华大学玉泉医院神经内科主任 耿同超;关注脑卒中后抑郁[N];保健时报;2009年

9 王梅;脑卒中后为何闷闷不乐[N];大众卫生报;2007年

相关博士学位论文 前8条

1 尹思远;卒中后抑郁早期检测和治疗的新视角:一篇单脑科中心112例卒中后抑郁的回顾性分析[D];浙江大学;2014年

2 宋景贵;卒中后抑郁患者的认知、睡眠与自主神经功能的对照研究[D];南方医科大学;2007年

3 张滨斌;益肾疏肝法治疗脑卒中后抑郁的临床研究[D];北京中医药大学;2005年

4 程远;脑卒中后抑郁肾虚肝郁型的临床研究[D];北京中医药大学;2007年

5 炎彬;卒中后抑郁症发病机制研究及其小鼠模型建立[D];中国协和医科大学;2004年

6 晋秀林;调肝扶脾、化痰通络法针药并用治疗脑卒中后抑郁的临床研究[D];北京中医药大学;2014年

7 纪孝伟;卒中后抑郁大鼠脑内单胺类递质及FGF-2表达的研究[D];山东大学;2011年

8 蔡华;畅郁逍遥散对脑卒中后抑郁(PSD)小鼠作用机理的实验研究[D];湖北中医药大学;2010年

相关硕士学位论文 前10条

1 陈淑霞;卒中后抑郁相关因素多元回归分析[D];河北大学;2015年

2 张琳琳;卒中后抑郁的发病率及相关因素分析[D];泰山医学院;2014年

3 邓懿函;针刺治疗卒中后抑郁的临床疗效及对血浆中同型半胱氨酸含量的影响[D];福建中医药大学;2015年

4 申龙燮;脑卒中后抑郁患者SEP与血浆5-羟色胺的临床意义[D];延边大学;2015年

5 盛雷;益肾解郁方治疗肾虚肝郁型脑卒中后抑郁的临床研究[D];安徽中医药大学;2015年

6 翟飞;卒中后抑郁患者丘脑磁共振氢质子波谱分析研究[D];新乡医学院;2015年

7 任伟华;中风解郁汤结合氟西汀治疗卒中后抑郁临床研究[D];新乡医学院;2015年

8 李艳涛;卒中后抑郁患者外周血单个核细胞p11基因表达的变化[D];新乡医学院;2015年

9 李凡;重复经颅磁刺激联合氟西汀对卒中后抑郁的临床疗效研究[D];昆明医科大学;2015年

10 崔燕;卒中后抑郁患者血清标志物变化及其影响因素探讨[D];青岛大学;2015年



本文编号:1828134

资料下载
论文发表

本文链接:https://www.wllwen.com/yixuelunwen/shenjingyixue/1828134.html


Copyright(c)文论论文网All Rights Reserved | 网站地图 |

版权申明:资料由用户ccdfd***提供,本站仅收录摘要或目录,作者需要删除请E-mail邮箱bigeng88@qq.com